Syntax Advisors’s Elevance Health ELV Stock Holding History

Syntax Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$256K	Buy	589 +30	+5%	+$13.6K	0.23%	97
2023 Q2	$248K	Sell	559 -40	-7%	-$18.5K	0.2%	121
2023 Q1	$275K	Buy	599 +74	+14%	+$35.2K	0.21%	93
2022 Q4	$269K	Sell	525 -67	-11%	-$34K	0.22%	93
2022 Q3	$269K	Buy	592 +28	+5%	+$13.4K	0.23%	93
2022 Q2	$272K	Buy	564 +4	+0.7%	+$1.98K	0.23%	91
2022 Q1	$275K	Sell	560 -294	-34%	-$134K	0.23%	98
2021 Q4	$396K	Buy	+854	New	+$359K	0.29%	54

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Syntax Advisors's ELV Position: Q3 2023 in Review

Syntax Advisors increased its Elevance Health (ELV) stake by 5.4% in Q3 2023, buying an estimated $13.6K and bringing the position to 589 shares worth $256K. The position accounts for 0.23% of the portfolio, ranked #97.

Syntax Advisors first reported a position in ELV in Q4 2021 and has held it in 8 quarters since. The position peaked at $396K in Q4 2021. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

Syntax Advisors held 589 shares of Elevance Health worth $256K as of Q3 2023.
Syntax Advisors bought 30 Elevance Health shares in Q3 2023, an estimated $13.6K.
Elevance Health made up 0.23% of Syntax Advisors's portfolio in Q3 2023, its #97 holding.
Syntax Advisors first reported a position in Elevance Health in Q4 2021 and has held it in 8 quarters since.
Syntax Advisors's Elevance Health position peaked at $396K in Q4 2021.
1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.